Primary Peritoneal High Grade Serous Adenocarcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11740 | Adavosertib | 0 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 0 | Active Not Recruiting | 1 |
DB11105 | Benzalkonium | 1 | Recruiting | 1 |
DB00958 | Carboplatin | 1 | Recruiting | 1 |
DB12483 | Copanlisib | 1 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 1 | Recruiting | 1 |
DB00441 | Gemcitabine | 1 | Active Not Recruiting | 1 |
DB11743 | Ipatasertib | 1 | Recruiting | 1 |
DB16252 | Nedisertib | 1 | Recruiting | 1 |
DB11793 | Niraparib | 1 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 1 |
DB00759 | Tetracycline | 1 | Recruiting | 1 |
DB11782 | Birinapant | 1 / 2 | Withdrawn | 1 |
DB00958 | Carboplatin | 1 / 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 / 2 | Withdrawn | 1 |
DB01229 | Paclitaxel | 1 / 2 | Active Not Recruiting | 1 |
DB08877 | Ruxolitinib | 1 / 2 | Active Not Recruiting | 1 |
DB14809 | Anetumab ravtansine | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB11771 | Tremelimumab | 2 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 / 3 | Active Not Recruiting | 1 |